Navigation Links
Avaxia Biologics, Inc. Awarded BARDA Contract for Therapeutic Countermeasure to Help the Nation Respond to a Radiological Emergency
Date:8/3/2011

WAYLAND, Mass., Aug. 3 , 2011) /PRNewswire/ -- Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today it was awarded a contract with the Biomedical Advanced Research and Development Authority (BARDA), for the research and development of an oral antibody therapy to mitigate the gastrointestinal damage that follows radiation exposure that might occur after a nuclear incident. The contract totals $2.9 million over 2 years provided that key milestones are achieved. Should Avaxia's program meet its anticipated endpoints at the end of this contract, the company hopes to pursue future opportunities with BARDA.  

Dr. Barbara Fox, Avaxia's CEO, commented, "We are very pleased to receive this contract and are proud to be working on this program related to our country's national defense. With this funding, we will be advancing our oral antibody product through the key efficacy studies needed to support the product's use as a nuclear threat countermeasure. This contract will permit us to complete the pre-clinical pharmacology studies for this potential therapy. We look forward to working with BARDA to develop a novel drug that can effectively protect the gastrointestinal tract from radiation damage.

This award provides Avaxia with a new drug development program that is of significant benefit to the company.  Besides providing the company with additional scientific infrastructure, the research to be conducted on this therapeutic will contribute to and support our innovative technology platform and bolster work being done in the related field of inflammatory bo
'/>"/>

SOURCE Avaxia Biologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Avaxia Biologics, Inc. to Present Key Pre-Clinical Inflammatory Bowel Disease Remission Data at Biotech Showcase 2011
2. Avaxia Biologics Awarded Phase I SBIR Grant to Develop Oral Antibody Therapeutic for Celiac Disease
3. Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
4. China Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
5. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
6. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
7. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
8. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
9. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
10. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
11. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/7qs3dw/corporate ... Reputation of Pharma in 2014 - a Perspective of ... their offering. This independent study, funded by ... with an interest in diabetes on the corporate reputation ... industry as a whole) in 2014. The results from ...
(Date:4/17/2015)... April 17, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), ... of innovative therapeutics for the treatment of cancer and ... presentation of data from three of its most advanced ... Research (AACR) 106 th Annual Meeting being held ... USA. The presentation on ...
(Date:4/16/2015)... , April 16, 2015  Hologic, Inc. (NASDAQ: ... cancer screening study i published on-line this ... journal of the American Cancer Society. ... the University of Pittsburgh Medical Center, supports current consensus guidelines ... that women 30-65 years of age be co-tested ...
Breaking Medicine Technology:Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4
... Clinical studies show Treximet provided significantly more patients ... relief compared to sumatriptan 85 mg, LONDON, April 15 ... (Nasdaq: POZN ) announced today that the FDA has,approved ... aura in adults. Treximet is the first and only migraine ...
... Summary: Genmab has,announced that HuMax-EGFr (zalutumumab) ... epidermal growth factor receptor (EGFr),molecules into a ... EGFr is central to its role in ... effective inhibition of cancer cell growth., ...
Cached Medicine Technology:Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 2Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 3Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 4Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 5Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 6Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine 7Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS 2Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS 3
(Date:4/19/2015)... Insurancecarsinsurance.com has released a new blog post making ... weather can affect auto insurance premiums . ... auto insurance premiums. In some Northern states like Wisconsin, ... than in other parts. The newly released blog post ... several months and what impact, if any, it will ...
(Date:4/19/2015)... April 19, 2015 McCann Investigations, a ... announce the publication of white paper Married, but ... As online media provides a unique environment of ... market specifically targeting adulterous spouses has emerged. Social ... becomes as easy as shopping online. Dating sites ...
(Date:4/18/2015)... 2015 For some people, tattoos are works ... the rest of their lives, as they have spent a ... in a great amount of thought on their designs. For ... outgrown them or simply want them removed for personal or ... tattoo, and in 2012-13 there was a 43 percent increase ...
(Date:4/18/2015)... 2015 Carinsurancesavings.biz has released a new ... are cheaper during Spring. , Spring can be ... Drivers should make sure they compare the newest policies ... can learn more about Spring car insurance offers by ... insurance quotes are becoming more and more popular. Many ...
(Date:4/18/2015)... SMITHTOWN, NEW YORK (PRWEB) April 18, 2015 ... Inc. (AMO) are hosting a ‘Strategies for Success’ program ... & Refractive Surgeons meeting in San Diego, where eye ... ‘Distinguished Moderator’ for this invitation-only event. Dr. Martin is ... AMO and Review of Ophthalmology chose Dr. Martin to ...
Breaking Medicine News(10 mins):Health News:Bad Weather Can Cause Accidents and Affect Auto Insurance Prices! 2Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2
... continued success, company offers new platform for general ... ... surgical device company, launched the TLS3 Tissue Ligating Shears,at the American ... With the introduction of this new platform, Starion is,building upon its ...
... at Event Dedicated to Women in New York City Living with ... ... Breast Cancer Network,(MBCN) today announced that October 13, 2007, has been ... Mayor Michael,Bloomberg. Metastatic Breast Cancer Awareness Day will be held in,conjunction ...
... Evaluation of ATIR by Dr. Velardi for ... Mismatched Bone Marrow Transplantation, AMSTERDAM, Netherlands, ... physician initiated European Phase II,clinical study for its lead product ... the successful treatment of,thirteen end stage blood cancer patients with ...
... inn and spa will open in late spring 2009, ... estate-style,inn, timeless in design and rising from a gentle ... accommodations in the Willamette,Valley,s famed pinot noir wine region, ... GGLO. A detailed description of the inn, spa, ...
... Oct. 9 Elvira, Mistress of the,Dark, will host ... party fundraiser benefiting AIDS Healthcare Foundation.,This wicked-cool event will ... in Hollywood at 6210 West Sunset Blvd. on Thursday, ... will feature a fashion show and contest,highlighting the unique ...
... 9 The Oregon Rehabilitation,Association (ORA), http://www.oregonrehabilitation.org, ... workers this October with National,Disability Employment Awareness Month. ... October to help increase the public,s awareness of,American ... the,entire month of October in 1988. This ...
Cached Medicine News:Health News:Starion Instruments Launches Next-Generation Tissue Ligating Shears at the American College of Surgeons Clinical Congress 2Health News:Mayor's Office Declares October 13 as First Metastatic Breast Cancer Awareness Day for New York City 2Health News:Mayor's Office Declares October 13 as First Metastatic Breast Cancer Awareness Day for New York City 3Health News:Kiadis Pharma Announces ATIR Interim Clinical Results 2Health News:Kiadis Pharma Announces ATIR Interim Clinical Results 3Health News:Details of Oregon Wine Region's First Luxury Inn, Spa Revealed at Groundbreaking Ceremony 2Health News:Details of Oregon Wine Region's First Luxury Inn, Spa Revealed at Groundbreaking Ceremony 3Health News:Details of Oregon Wine Region's First Luxury Inn, Spa Revealed at Groundbreaking Ceremony 4Health News:'Something Wicked!' This Way Comes: Elvira Hosts Halloween Fashion Show and Fundraiser Benefiting AIDS Healthcare Foundation 2Health News:October Is National Disability Employment Awareness Month 2
... Developed specifically to disintegrate renal ... features state-of-the-art technology in a ... exceptionally efficient and affordable lithotripsy ... highest level of clinical results ...
... to treatment is accurate diagnosis of the ... quick, patient-friendly tool designed to aid in ... minimizing patient discomfort. Designed for in-office use, ... type of urethral pressure measurement for stress ...
...
...
Medicine Products: